Anti-estrogen therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-estrogen therapy, covering 2006-09-13 to 2023-04-19. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer [Phase 2]